logo
FLGT_building
The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Fulgent had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulgent Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2022 - (NASDAQ: FLGT)

The Gross Law Firm issues the following notice to shareholders of Fulgent Genetics, Inc

By AP News
Published - Nov 16, 2022, 05:48 AM ET
Last Updated - Jul 30, 2024, 07:17 AM EDT

NEW YORK, Nov. 16, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fulgent Genetics, Inc.

Shareholders who purchased shares of FLGT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
4.2 12182024